Status:
RECRUITING
Investigating the Impact of Duration and Amount of Light on the Circadian System Response - Aim 3
Lead Sponsor:
Icahn School of Medicine at Mount Sinai
Collaborating Sponsors:
National Institute on Aging (NIA)
Conditions:
Alzheimer's Disease
Mild Cognitive Impairment
Eligibility:
All Genders
55+ years
Phase:
NA
Brief Summary
Investigate the long-term impact of amount and duration of Tailored Lighting Intervention (TLI) obtained from Aims 1 and 2 on sleep, cognition, circadian marker, mood, and behavior in AD/ADRD patients...
Eligibility Criteria
Inclusion
- Diagnosis of Alzheimer's disease or related dementia with a Montreal Cognitive Assessment score \<25
- Sleep disturbance with a Pittsburgh Sleep Quality Index score ≥5
Exclusion
- Extensive brain vascular disease, traumatic brain injury, multiple sclerosis, Parkinson's Disease
- Obstructing cataracts
- Severe macular degeneration
- Use of sleep medication
- Use of oral melatonin
- untreated moderate to severe sleep apnea
- Severe restless leg syndrome - Blindness
Key Trial Info
Start Date :
December 3 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 31 2027
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06595030
Start Date
December 3 2024
End Date
January 31 2027
Last Update
May 29 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Icahn School of Medicine at Mount Sinai
Menands, New York, United States, 12204
2
Icahn School of Medicine at Mount Sinai
New York, New York, United States, 10029